NIPER PhD Scholars Revised Fellowship approved by Department of Pharmaceuticals

WhatsApp D. Pharma Group Join Now
Telegram D. Pharma Group Join Now
Telegram Group Latest Pharma Jobs Join Now
Telegram B. Pharma Group Join Now
Telegram Medicine Update Group Join Now
WhatsApp B. Pharma/ GPAT Channel Join Now

Exciting news for PhD scholars at the National Institutes of Pharmaceutical Education & Research (NIPER)! The Department of Pharmaceuticals (DoP) has given its nod for a significant revision in the fellowship rates, aligning them with the latest standards approved by the Department of Higher Education. Effective January 1, 2023, this revision promises enhanced emoluments for scholars, marking a positive shift in the support provided to those engaged in pharmaceutical research.


In this SEO-friendly news blog, we’ll delve into the details of the fellowship revisions, highlighting the increased emoluments for Junior Research Fellows (JRF), Senior Research Fellows (SRF), and Research Associates (RA). Let’s explore how these changes contribute to fostering a conducive research environment for scholars at NIPER.

Key Highlights:
1. JRF Emoluments Increased: As per the circular dated September 11, 2023, JRFs with a postgraduate degree in basic science or a graduate/postgraduate degree in a professional course will now receive Rs. 37,000 per month, up from Rs. 31,000.
2. Enhanced SRF Emoluments: SRFs, with the qualifications prescribed for JRF along with two years of research experience, will see their emoluments rise from Rs. 35,000 to Rs. 42,000 per month.
3. Revision for Research Associates: The emoluments for Research Associates have also been revised – from Rs. 47,000 to Rs. 58,000 for Research Associate I, Rs. 49,000 to Rs. 61,000 for Research Associate II, and Rs. 54,000 to Rs. 67,000 for Research Associate III.
4. Mandatory Assessment for Upgradation: Scholars will undergo an external assessment after two years to transition from JRF to SRF. Successful assessment is a prerequisite for the award of SRF, with annual satisfactory assessments mandatory during the SRF period.
5. Leave Entitlement and Benefits: While JRFs and SRFs are eligible for casual leave, Research Associates are entitled to leave as per the rules of the host institution. None of the categories are entitled to dearness allowance, bonus, leave travel concession, or retirement benefits.
6. Publication Guidelines: Scholars are encouraged to publish their research work in standard refereed journals, acknowledging the support of the Government of India in all publications.
7. Financial Support: The additional expenditure due to the fellowship revision for the current financial year will be met from the existing budgetary grant, ensuring the sustainability of the program.

The DoP’s commitment to aligning NIPER fellowship rates with recognized standards reflects the government’s dedication to supporting cutting-edge pharmaceutical research. This move is poised to elevate the research landscape at NIPERs, contributing to the growth and development of the pharmaceutical sector in India. Stay tuned for more updates on how these revisions impact the journey of scholars in the field of pharmaceutical education and research.

<<<<<<<<<<<<<MORE NEWS>>>>>>>>>>>>>>>>

Redwing & Samridh Launches Groundbreaking Drone Network for Healthcare Delivery in Odisha’s Rayagada District  Click  Here
Unlocking the Sleep-Health Connection: Chronic Sleep Deficiency and Increased Insulin Resistance in Women, Especially Postmenopausal  Click  Here
National Pharmacy Commission Bill Introduces Pharmacy Advisory Council for Enhanced Regulation  Click  Here
Health Ministry Unveils Draft National Pharmacy Commission Bill 2023 – What You Need to Know Click  Here
The NPPA Sets a Price Cap on Nine Planned Formulations, one of which is a Medication for Brain Cancer Click  Here


<<<<<<<<<<<<<JOIN US>>>>>>>>>>>>>>>>

Subscribe our PHARMACY INDIA Youtube Channel for more Pharma Updates Click Here
Follow us on Instagram Click Here
Download PHARMACY INDIA MOBILE APP from Google Play Store  Click Here
Follow us on LinkedIn Click Here


Please enter your comment!
Please enter your name here